The PCCTC's phase 2 study of talazoparib with or without enzalutamide in patients With metastatic castration-resistant prostate cancer and HRR mutations after progression on abiraterone acetate (TALENT) is now actively enrolling. To learn more visit clinicaltrials.gov/study/NCT068...

Pembrolizumab plus enzalutamide and androgen deprivation therapy versus placebo plus enzalutamide and androgen deprivation therapy for metastatic hormone-sensitive #ProstateCancer : the randomized, double-blind, phase III KEYNOTE-991 study annalsofoncology.org/article/S092...

Pembrolizumab plus enzalutamide and androgen deprivation therapy versus placebo plus enzalutamide and androgen deprivation therapy for metastatic hormone-sensitive prostate cancer: the randomized, double-blind, phase III KEYNOTE-991 study

Despite treatment advances, most patients with metastatic hormone-sensitive prostate cancer (mHSPC) experience disease progression to castration-resistant disease within 5 years. The placebo-controlled, double-blind, phase III KEYNOTE-991 study evaluated the efficacy and safety of adding pembrolizumab to enzalutamide and androgen deprivation therapy (ADT) in participants with mHSPC.

annalsofoncology.org

Congratulations to MSK's Dr. Justin Jee and Dr. Nikolaus Schultz for being accepted into Round 2 of @statnews.com #STATMadness. Vote for the team “Cancer Big Data” now: www.statnews.com/feature/stat...

Congratulations to MSK's Dr. Natasha Rekhtman and Dr. Charles Rudin for being accepted into Round 1 of @statnews.com #STATMadness. Vote for the team “New Lung Cancer Subtype” now: www.statnews.com/feature/stat...

Big news in prostate cancer treatment! The #FDA has expanded the label for Novartis #Pluvicto, now approved before chemotherapy for PSMA-positive metastatic castration-resistant prostate cancer. #TCSC #cancerresearch #prostatecancer #psmafore www.appliedclinicaltrialsonline.com/view/fda-app...

FDA Approves Expanded Label of Novartis’ Prostate Cancer Treatment, Pluvicto

Based on additional results from the Phase III PSMAfore clinical trial, the therapy is now approved for use prior to chemotherapy in PSMA-positive metastatic castration-resistant prostate cancer.

appliedclinicaltrialsonline.com

Adrenal androgens and overall survival (OS) in men with castration-resistant prostate cancer (CRPC) treated with enzalutamide without (ENZ) or with abiraterone and prednisone (ENZ/AAP). #GU25 @charlesryanmd.bsky.social @mjmorrismd.bsky.social @ascopost.bsky.social meetings.asco.org/abstracts-pr...

So privileged to be among friends and colleagues for the second Feng symposium. Felix was friend and exemplar to us all.

American Society of Clinical Oncology (ASCO) provides advisory support for the association between alcohol & cancer. @ascocancer.bsky.social @ascopost.bsky.social society.asco.org/news-initiat...

Oncology Society Urges Americans to Heed Surgeon General Advisory on Alcohol and Cancer

The U.S. Surgeon General’s office released a new advisory on the link between alcohol consumption and increased risk for cancer. The advisory reports alcohol use as the third leading preventable cause...

society.asco.org

AMBASSADOR Trial: Adjuvant pembrolizumab improved disease-free survival in high-risk muscle-invasive urothelial carcinoma post-surgery (29.6 vs 14.2 months; HR 0.73). Grade ≥3 AEs: 50.6%. @nejm.org @oncoalert.bsky.social @erplimackmd.bsky.social @drchoueiri.bsky.social @oncbrothers.bsky.social

@thepcctc.bsky.social is pleased to announce its Summer 2025 internships. Opportunities are available in Data Management, Data Science, and Clinical Operations. For more info please visit www.linkedin.com/posts/prosta...

The Prostate Cancer Clinical Trials Consortium (PCCTC) on LinkedIn: PCCTC Data Management Internship, Remote in | Careers at Remote

The Prostate Cancer Clinical Trials Consortium (PCCTC) is pleased to announce its Summer 2025 internships. Opportunities are available in Data Management, Data…

linkedin.com

Nobody capture the holiday spirit more than @mskcancercenter.bsky.social facilities and engineering staff. Thanks for lifting our spirits with your decorations!

Heartbroken💔we lost Dr. Felix Feng— close friend, selfless collaborator, brilliant scientist. We miss you--too early my friend. To all: please consider supporting this ACS/ASTRO award in Felix name: donate.cancer.org/g/tjjfqwdnrxrl…?

I just helped save a life

You can save one, too. Donate now.

donate.cancer.org

Telehealth Will Die In 3 Weeks Without Congressional Action www.forbes.com/sites/judyst...

Telehealth Will Die In 3 Weeks Without Congressional Action

Urgent action is needed to pass the Telehealth Modernization Act before it expires, ending telemedicine on Dec. 31. This would be devastating for disabled and rural patients.

forbes.com

A big thank you to the GU Oncologists and Nuc Meds of CTIC in Bogota, Colombia for their hospitality and scientific discussions. Great cancer center and #ProstateCancer care to be sure. Hope to work together in the future! Thanks to PCF for funding this scientific exchange.

Just in time for Thanksgiving, nice pathology framework for characterizing treatment emergent neuroendocrine #ProstateCancer, a biologically diverse entity that everyone has a hard time describing, in CCR - thanks to Michael Haffner and @mishabeltran.bsky.social aacrjournals.org/clincancerre...

Framework for the Pathology Workup of Metastatic Castration-Resistant Prostate Cancer Biopsies

Abstract. Lineage plasticity and histologic transformation from prostate adenocarcinoma to neuroendocrine prostate cancer (NEPC) occurs in up to 15-20% of patients with castration-resistant prostate c...

aacrjournals.org

Life could be a little bit hard for a junior scientist.

Proud of my sister. Calm, deliberative, and forward focused. @blandro.bsky.social youtube.com/watch?v=w2ft...

I remember my first-gen 128k Mac very fondly! Very musical drive noises...

Garth Beagle@garthbeagle.bsky.social · 2y ago

#fbf first test of a thrift store rescued Macintosh Performa 578 and it already has flying toasters installed 🥰

Thanks for the reminder! Really looking forward to the meeting this year.

Julie Gralow@jrgralow.bsky.social · 2y ago

ASCO annual meeting 2025 abstract submitter open - closes Jan 28th. To support global innovation in cancer research, payment waivers offered to 1st authors from low- & lower-middle-income countries (World Bank)! Apply for a waiver when you submit an abstract conferences.asco.org/am/abstract-...

Good write up of BlueSky #MedSky by @kristinafiore.bsky.social feat. BlueSky elders: @mdaware.org @gavinyamey.bsky.social @nickmark.bsky.social @kiswanson.bsky.social and @kidneyboy.bsky.social of course www.medpagetoday.com/special-repo...

Physicians Flock to Bluesky, Hoping to Leave X Behind

Many compare it to the early days of Twitter

medpagetoday.com